Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 7/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.48 |
| ▸ | APP | P05067 | 7/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | PLEC | Q15149 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.34 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14634491 | 0.87 | MAPT (0.39) | MAPTALDH1A1MEN1KMT2AAPP | |
| SCHEMBL14634382 | 0.85 | MAPT (0.38) | MAPTALDH1A1MEN1KMT2AAPP | |
| SCHEMBL711589 | 0.79 | MAPT (0.45) | MAPTALDH1A1MEN1KMT2AAPP | |
| SCHEMBL14634376 | 0.77 | MAPT (0.36) | MAPTALDH1A1MEN1KMT2AAPP | |
| Diphenylamine SCHEMBL14634383 | 0.77 | TRPA1 (0.35) | MAPTALDH1A1MEN1KMT2AAPP | |
| SCHEMBL22102776 | 0.74 | MEN1 (0.44) | MAPTALDH1A1MEN1KMT2AAPP | |
| SCHEMBL14634373 | 0.74 | MAPT (0.39) | MAPTALDH1A1MEN1KMT2AAPP | |
| SCHEMBL29090586 | 0.74 | MAPT (0.35) | MAPTALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL31314381 | 0.74 | MAPT (0.35) | MAPTALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL29102222 | 0.73 | ALDH1A1 (0.41) | MAPTALDH1A1MEN1KMT2AAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103820-A1 | METHOD FOR PREPARING FULLERENE SINGLE-CRYSTAL FILMS AND USES FIELD OF TECHNOLOGY | ZHEJIANG UNIVERSITY (CN) | 2026-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103820-A1 | METHOD FOR PREPARING FULLERENE SINGLE-CRYSTAL FILMS AND USES FIELD OF TECHNOLOGY | CCNE2, MDM4, FSCN1 | MAPT 946/4885ALDH1A1 4607/4885MEN1 1856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.